#Retina care is shifting, and Dr. Deepak Sambhara breaks down what that really looks like inside a busy clinic. 👁️
Telemedicine isn’t replacing eye exams but it is becoming a valuable tool to manage the record number of retina patients coming through the door. Home #OCT, AI-assisted image review, and remote testing are creating ways to catch issues earlier, cut unnecessary visits, and ease the strain on both patients and providers.
Dr. Sambhara also raises an important point: the biggest impact may come from putting familiar diagnostic tools in new settings. Primary care offices equipped with OCT or fundus imaging, supported by #AI that helps identify true pathology, could change how patients enter the retina pathway altogether.
#Telemedicine won’t replace real-time, in-person decision making. But used thoughtfully, it can support clinic flow, reduce burnout, and make care more efficient without lowering the standard patients depend on.
Financial Disclosures: Genentech, Astellas, Ocular Therapeutix, Heidelberg, Regeneron,
3